Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024...
Shanghai Henlius Biotech, Inc. (2696.HK) et Organon (NYSE : OGN) ont annoncé aujourd’hui que l’Agence européenne des médicaments (EMA) a validé les demandes d’autorisation de mise sur le marché...
(ビジネスワイヤ) -- シャンハイ・ヘンリウス・バイオテック(2696.HK)とオルガノン(NYSE:OGN)は、欧州医薬品庁(EMA)が、Prolia®およびXgeva ®(デノスマブ)のバイオシミラーの治験薬であるHLX14の販...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -0.396825396825 | 20.16 | 20.55 | 19.94 | 1191384 | 20.1560453 | CS |
4 | -0.5 | -2.42954324587 | 20.58 | 21.4399 | 19.82 | 1532745 | 20.4852741 | CS |
12 | 2.53 | 14.415954416 | 17.55 | 21.98 | 17.38 | 1816450 | 20.06707262 | CS |
26 | 3.88 | 23.950617284 | 16.2 | 21.98 | 15.33 | 2233549 | 18.38529173 | CS |
52 | -0.07 | -0.347394540943 | 20.15 | 24.08 | 10.835 | 3137461 | 16.70547843 | CS |
156 | -9.87 | -32.9549248748 | 29.95 | 39.475 | 10.835 | 2361922 | 23.85073513 | CS |
260 | -14.12 | -41.2865497076 | 34.2 | 39.475 | 10.835 | 2507884 | 24.49417371 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.